Love the explanation for why the AML mouse model results have been delayed... '"the optimal Zantrene and Decitabine dose controlled the growth of the cancer to such an extent that the mice have lived far longer than expected"
- Forums
- ASX - By Stock
- RAC
- Ann: December 2022 Preclinical & Clinical Programs Update
Ann: December 2022 Preclinical & Clinical Programs Update, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.92 |
Change
-0.090(4.48%) |
Mkt cap ! $350.7M |
Open | High | Low | Value | Volume |
$2.04 | $2.09 | $1.92 | $488.5K | 241.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | $1.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.95 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | 1.965 |
1 | 256 | 1.960 |
1 | 51 | 1.950 |
1 | 1399 | 1.945 |
1 | 4568 | 1.940 |
Price($) | Vol. | No. |
---|---|---|
1.980 | 8543 | 2 |
1.985 | 1200 | 1 |
1.990 | 3600 | 1 |
1.995 | 4585 | 3 |
2.000 | 3000 | 1 |
Last trade - 13.17pm 19/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online